                         SEQUENCE LISTING

<110>  Immunovaccine Technologies Inc.
 
<120>  Vaccine Compositions Comprising an Amphipathic Compound, a 
       Neoantigen and a Hydrophobic Carrier, and Methods of Use Thereof

<130>  78961-198

<150>  US 62/331,770
<151>  2016-05-04

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-helper epitope from tetanus toxoid peptide (A16L)

<400>  1

Ala Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15      


<210>  2
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mut30 Neoantigen

<400>  2

Pro Ser Lys Pro Ser Phe Gln Glu Phe Val Asp Trp Glu Asn Val Ser 
1               5                   10                  15      


Pro Glu Leu Asn Ser Thr Asp Gln Pro Phe Leu 
            20                  25          


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CpG Oligonucleotide

<400>  3
tccatgacgt tcctgacgtt                                                   20


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Palmitic Acid Adjuvant


<220>
<221>  Misc_feature
<222>  (1)..(1)
<223>  Linked to PAM2 or PAM3

<400>  4

Cys Ser Leu Leu Leu Leu 
1               5       


<210>  5
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  26-mer single-stranded polyI:C


<220>
<221>  Modified_base
<222>  (1)..(1)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (3)..(3)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (5)..(5)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (7)..(7)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (9)..(9)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (11)..(11)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (13)..(13)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (15)..(15)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (17)..(17)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (19)..(19)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (21)..(21)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (23)..(23)
<223>  Inosine

<220>
<221>  Modified_base
<222>  (25)..(25)
<223>  Inosine


<400>  5
ncncncncnc ncncncncnc ncncnc                                            26


<210>  6
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PADRE T-helper epitope


<220>
<221>  Misc_feature
<222>  (3)..(3)
<223>  Xaa may be cyclohexylalanyl

<400>  6

Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Ala 
1               5                   10              


<210>  7
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-helper epitope from tetanus toxoid peptide (F21E)

<400>  7

Phe Asn Asn Phe Thr Val Ser Phe Trp Leu Arg Val Pro Lys Val Ser 
1               5                   10                  15      


Ala Ser His Leu Glu 
            20      


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Irrelevant peptide (R9F)

<400>  8

Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Irrelevant peptide

<400>  9

Glu Gly Pro Arg Asn Gln Asp Trp Leu
1               5                   